Optimizing Immune Checkpoint Inhibitor/Targeted Therapy Combination Adverse Event Management

Get personalized guidance on managing immune-related AEs for your patients with our newly updated Interactive Decision Support Tool adapted from the latest NCCN guidelines. Then, gain multidisciplinary insights into managing toxicities from ICI/targeted therapy combination regimens with an expert text module and downloadable slides.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca, Eisai, Merck Sharp & Dohme LLC, and Regeneron Pharmaceuticals, Inc.

AstraZeneca

Eisai

Merck Sharp & Dohme, LLC

Regeneron Pharmaceuticals, Inc